New treatment for joint scarring after surgery
Official title: Novel therapy for arthrofibrosis
Funded at Panorama Research, INC. · NIH-10759562 · Data updated 2026-11-12
This study is testing a new treatment that uses an antibody to help reduce unwanted scar tissue and stiffness in joints after surgery, making it easier for people to heal and move comfortably.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Panorama Research, INC. NIH-funded |
| Lab location | 1 site (Sunnyvale, United States) |
| Project start | September 26, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $275,765 |
| NIH project number | 1R43AR082791-01A1 |
| Project ID | NIH-10759562 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have undergone joint surgery and are experiencing symptoms of arthrofibrosis.
✕Less likely to help
Patients who have not had joint surgery or do not exhibit signs of arthrofibrosis may not benefit from this research.
What this research studies
This research investigates a novel therapy aimed at reducing arthrofibrosis, a common complication following joint surgeries characterized by excessive scar tissue formation. The approach involves using an antibody that blocks specific interactions necessary for collagen fibril formation, which is responsible for the unwanted scarring. By inhibiting this process, the therapy aims to promote better healing and reduce stiffness in affected joints. The research includes in vivo studies in animal models to assess the safety and effectiveness of this treatment.
Why it matters
Potential benefit: If successful, this research could lead to improved recovery and mobility for patients who undergo joint surgeries.
How similar studies have gone: Previous research has shown promise in using similar antibody-based approaches to modulate collagen formation, indicating potential for success in this novel application.
Where this research is happening
-
Panorama Research, INC.
Sunnyvale, United States Active
Researchers
- Principal investigator: Larrick, James W — Panorama Research, INC.
- Study coordinator: Larrick, James W
Related research
Other NIH-funded projects on the same topics.
-
Novel macrophage repolarization therapy for colorectal cancer
A new treatment approach aims to reshape the immune cells in colorectal cancer to help the body fight the disease, especially for patients who don’t have a strong response to current immunotherapies.
-
New treatment to stop bone loss in severe gum disease
This study is testing a new treatment to help prevent bone loss in your jaw caused by severe gum disease, using a special antibody to target certain proteins, and it's designed for adults dealing with this common issue.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.